Hyderabad, August 14 : OMICs Group, in collaboration with Bio Genesis, Federation of Asian Biotech Association (FABA) and Kenes Exhibitions will jointly organise the “Global Cancer Summit: Recent advances in cancer diagnosis and therapy” from September 16-18, 2014.
The conference to be held at HICC will be inaugurated by President of India Pranab Mukherjee while Nobel laureate for Physiology/Medicine (1997) Dr Andrew V Schally and Dr Dattatreyudu, Executive Vice-Chairman of the radiation Oncology Dept, The New York Presbyterian Hospital will be the Guest of Honour.
Addressing a press conference here on Wednesday, BioGenesis Euro Indian Health Cluster’s Scientific Advisor Dr VP Rao said that the conference aims to make an assessment of economic burden of cancer that includes direct expenditure on detection, treatment, morbidity cost with productivity loss for employers, patients and their families. He said continued advancements in Cancer therapies were allowing the specialists to tailor the treatment to each individual patient in order to achieve cost effective, best results, fewer side effects and overall better outcomes.
According to the World Cancer Research Fund (WCRF), as many as 2.8 million new cancer cases are registered every year globally linked to diet, lifestyles and the body weight. The UN World Cancer Research Fund also issued a warning that the World Cancer figures raised by fifth in less than 10 years, which is four times greater that the new HIV cases registered.
In India, nearly 10 lakh new cancer patients are diagnosed every year while over 6.33 lakh cancer deaths diagnosed every year including 17,600 in Andhra Pradesh alone. There are 27 Cancer Centres, 118 government hospitals and 163 private hospitals treating cancer patients across the country. There are nearly 1,500 qualified oncologists and 502 qualified psychologists while 38 Foundations, including NGOs, are working for cancer. There are nearly 300 radiotherapy machines available in working condition in the country. INN